Cytokinetics

Cytokinetics is a late-stage biopharmaceutical company committed to developing potential medicines for people with diseases of impaired muscle function. Based in the United States, the company has approximately 201 employees and is focused on advancing its robust pipeline of small molecule muscle activators and inhibitors to address conditions such as heart failure and hypertrophic cardiomyopathy.